- Home
- PSQH vs UNCY Comparison
PSQH vs UNCY Comparison
Compare PSQH & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSQH
- UNCY
- Stock Information
- Founded
- PSQH 2021
- UNCY 2016
- Country
- PSQH United States
- UNCY United States
- Employees
- PSQH N/A
- UNCY N/A
- Industry
- PSQH Advertising
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- PSQH Consumer Discretionary
- UNCY Health Care
- Exchange
- PSQH Nasdaq
- UNCY Nasdaq
- Market Cap
- PSQH 97.5M
- UNCY 91.0M
- IPO Year
- PSQH N/A
- UNCY 2021
- Fundamental
- Price
- PSQH $2.30
- UNCY $4.95
- Analyst Decision
- PSQH Strong Buy
- UNCY Strong Buy
- Analyst Count
- PSQH 2
- UNCY 4
- Target Price
- PSQH $6.00
- UNCY $63.75
- AVG Volume (30 Days)
- PSQH 468.1K
- UNCY 1.2M
- Earning Date
- PSQH 08-13-2025
- UNCY 08-13-2025
- Dividend Yield
- PSQH N/A
- UNCY N/A
- EPS Growth
- PSQH N/A
- UNCY N/A
- EPS
- PSQH N/A
- UNCY N/A
- Revenue
- PSQH $26,483,166.00
- UNCY N/A
- Revenue This Year
- PSQH $85.17
- UNCY N/A
- Revenue Next Year
- PSQH $61.98
- UNCY $1,458.53
- P/E Ratio
- PSQH N/A
- UNCY N/A
- Revenue Growth
- PSQH 201.84
- UNCY N/A
- 52 Week Low
- PSQH $1.63
- UNCY $2.02
- 52 Week High
- PSQH $7.77
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- PSQH 58.61
- UNCY 43.02
- Support Level
- PSQH $2.07
- UNCY $4.31
- Resistance Level
- PSQH $2.30
- UNCY $5.55
- Average True Range (ATR)
- PSQH 0.13
- UNCY 0.76
- MACD
- PSQH 0.03
- UNCY -0.10
- Stochastic Oscillator
- PSQH 94.20
- UNCY 16.26
About PSQH PSQ Holdings Inc.
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.